| 2541 |
Formulation and Evaluation of Rofecoxib Capsules, Saudi Journal of Pharmaceutical Sciences, Vol. 17, No. 1, January (2009). |
Department of Industrial Pharmacy |
2009 |
| 2542 |
Formulation of ketorlac tromethamine in semi-solid dosage forms. |
Department of Pharmaceutics |
2009 |
| 2543 |
Formulation of ketorlac tromethamine in semi-solid dosage forms. |
Department of Pharmaceutics |
2009 |
| 2544 |
Formulation of ketorlac tromethamine in semi-solid dosage forms. |
Department of Pharmaceutics |
2009 |
| 2545 |
Identifying Transfer Mechanisms and Sources of
Decabromodiphenyl Ether (BDE 209) in Indoor Environments
Using Environmental Forensic Microscopy |
Department of Pharmaceutical Analytical Chemistry |
2009 |
| 2546 |
Improvement of Solubility and Dissolution Rate of
Indomethacin by Solid Dispersions in Gelucire 50/13 and
PEG4000 |
Department of Pharmaceutics |
2009 |
| 2547 |
Improvement of Solubility and Dissolution Rate of
Indomethacin by Solid Dispersions in Gelucire 50/13 and
PEG4000 |
Department of Pharmaceutics |
2009 |
| 2548 |
Improvement of solubility and dissolution rate of indomethacin by solid dispersion in Gelucire 50/13 and PEG 4000. |
Department of Pharmaceutics |
2009 |
| 2549 |
Improvement of solubility and dissolution rate of indomethacin by solid dispersion in Gelucire 50/13 and PEG 4000. |
Department of Pharmaceutics |
2009 |
| 2550 |
Improvement of solubility and dissolution rate of indomethacin by solid dispersion in Gelucire 50/13 and PEG 4000. |
Department of Pharmaceutics |
2009 |